Update on the New COVID-19 Strain: What You Need to Know

Update on the New COVID-19 Strain: What You Need to Know

svk_minhhuy

Estimated reading time: 5 minutes

As of May 2025, global health agencies, including the WHO and CDC, are tracking a new wave of COVID-19 activity driven by two notable subvariants: LP.8.1 and NB.1.8.1, both derived from the JN.1 lineage. Although these variants have not shown increased severity, their higher transmissibility and immune evasion capacity are renewing global public health concerns.


🧬 What Are the New Variants?

LP.8.1

  • A sublineage of the JN.1 variant
  • Now responsible for over 70% of confirmed COVID-19 cases in the U.S.
  • Associated with fast person-to-person spread in community and travel settings
  • Considered a Variant Under Monitoring (VUM) by the WHO (WHO, 2025)

NB.1.8.1

  • First identified in travelers arriving at U.S. airports
  • Linked to rising case clusters in Southeast Asia and China
  • Shows increased binding affinity to ACE2 receptors, making it more infectious than prior subvariants (Economic Times, 2025)

šŸ¤’ Recognizing the Symptoms

While LP.8.1 and NB.1.8.1 do not appear to cause more severe disease than previous Omicron strains, their symptoms can be easily mistaken for the common cold or flu:

  • Persistent sore throat
  • Fatigue and malaise
  • Dry cough or productive cough
  • Runny nose or sinus congestion
  • Headaches and muscle aches
  • Fever, chills, or night sweats

Less common but notable symptoms include:

  • Gastrointestinal upset (nausea, mild diarrhea)
  • Loss of smell or taste (less frequent but still possible)
  • Brain fog or slowed cognition

Many infected individuals report milder symptoms but extended recovery time. Testing is essential to distinguish COVID-19 from seasonal illnesses.

(Times of India, 2025)


šŸ’‰ Vaccine Response and Global Updates

In light of the variant spread:

  • The U.S. FDA has advised manufacturers to update vaccine formulations to target the JN.1 lineage, including LP.8.1.
  • Moderna has filed for approval of its reformulated vaccine for fall 2025 rollout. (Reuters, 2025)
  • The European Medicines Agency (EMA) also supports new vaccines targeting LP.8.1 for the 2025/2026 campaign. (EMA, 2025)

Experts suggest that while existing vaccines still offer protection against severe outcomes, updated boosters will provide better immunity against breakthrough infections.


šŸ›”ļø Prevention Still Matters

Even with vaccine updates, traditional preventive strategies remain vital:

  • Wear high-filtration masks (e.g., N95) in crowded indoor environments
  • Ensure good ventilation in enclosed spaces
  • Disinfect frequently touched surfaces
  • Wash hands thoroughly and regularly
  • Isolate promptly if symptomatic or testing positive

Healthcare authorities encourage frequent testing, particularly before travel or visiting high-risk individuals, to limit silent transmission.


🌿 Holistic Wellness and Immune Support

Incorporating daily wellness practices may enhance immune resilience and improve recovery outcomes:

  • Essential oils such as eucalyptus and lavender can reduce anxiety and support respiratory health
  • Herbal adaptogens like ashwagandha and elderberry help modulate stress and inflammation
  • Mindful movement (yoga, tai chi) supports lung capacity and stress regulation
  • Digital health tools (oximeters, thermometers, home test kits) help monitor changes early

Balanced nutrition, hydration, and restorative sleep remain essential in bolstering immunity against respiratory infections.


🧾 Final Thoughts

While the LP.8.1 and NB.1.8.1 subvariants are not triggering alarm due to severe illness, their rapid spread, immune evasion, and vaccine adaptation needs warrant close attention. Public health officials stress the continued value of testing, vaccination, masking, and self-care.

With timely action, updated science, and supportive habits, individuals and communities can stay protected as the virus continues to evolve.

Naturemā„¢ Herbal Lozenges Cough Free: Natural Relief for Your Respiratory Health

Discover gentle and effective relief withĀ Naturemā„¢ Herbal Lozenges Cough Free, a thoughtfully crafted remedy for cough and respiratory support. Each lozenge blendsĀ 14 powerful medicinal herbs, includingĀ Ginger extract,Ā Peppermint, andĀ Dang Shen Ginseng, known for their therapeutic properties.

  • Ease Throat Irritation: Soothe discomfort and calm persistent coughing.
  • Enhance Lung Function: Support clearer, healthier breathing.
  • Boost Immunity: Strengthen your body’s natural defenses.
  • Reduce Inflammation: Alleviate swelling and promote mucosal healing.

Naturemā„¢ Cough Free is designed to deliver natural, effective relief without harsh side effects, helping you breathe easier and feel better. Take a step toward improved respiratory health with this trusted herbal solution.

Reference

WHO (2025). Statement on the antigen composition of COVID-19 vaccines. who.int

Economic Times (2025). New COVID variant NB.1.8.1 detected at U.S. airports. economictimes.com

Times of India (2025). New COVID variant: early symptoms. timesofindia.indiatimes.com

Reuters (2025). Moderna files application for updated COVID vaccine. reuters.com

EMA (2025). ETF recommends updating COVID-19 vaccines. ema.europa.eu

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.